LVAD therapy then reduced Angiotensin I expression (22.54 ± 4.70 vs. 70.12 ± 64.62 AU, P = 0.084) irrespective of the heart failure etiology (i.e., DCM vs. ICM) or the time on LVAD. Here, AGT is linked to heart failure.